JOGO Health is Pioneering Pain-Free Futures
In the dawn of transformative healthcare, JOGO Health stands as a pioneer, steering clear of conventional treatments to introduce a revolutionary technology for chronic pain and neuromuscular disorders. This narrative weaves the story of a company reshaping the future of medical care through tenacity and innovative technology.
The Genesis of JOGO
The saga began in the 1980s with Dr. Joseph Brudny and Dr. Gordon Silverman, whose collaboration with IBM birthed a device that promised new hope for stroke recovery. Fast forward to 2010, and Sanjai Murali, inspired by the rapid advancements in mobile technology, transformed this invention into a wearable device integrated with an app, enhancing its accessibility and efficacy. Supported by Siva Nadarajah’s investment and co-founding partnership, this innovation evolved into JOGO — a company named in honor of its originators and dedicated to transforming lives.
Pioneering Non-invasive Pain Solutions
Millions grappling with chronic pain and neuromuscular disorders face an uphill battle daily, as the constant discomfort severely impedes their ability to perform everyday tasks and takes a significant mental toll. Historically, the primary treatments — pharmaceuticals and invasive surgeries — come with substantial drawbacks, including temporary relief, severe side effects, dependency, high costs, and lengthy recovery periods, often pushing patients to forego treatment entirely.
Recognizing this substantial gap in care, JOGO Health has pioneered a transformative, non-invasive solution harnessing the brain’s inherent neuroplasticity. JOGO’s wearable technology and app facilitate the brain’s ability to reorganize and form new neural connections, effectively addressing the root causes of pain and dysfunction without the adverse effects associated with traditional treatments. Supported by a study from Harvard Medical School, JOGO’s approach has proven more effective than opioids in treating conditions like chronic lower back pain.
With its AI-driven technology, JOGO offers a range of treatments for over 20 conditions, including stroke recovery, migraines, and more, providing a safe and effective alternative for individuals — including pregnant women and children — for whom traditional treatments may not be viable. JOGO’s patented platform, protected by 18 patent claims, represents a major leap forward in medical technology, offering long-term relief for conditions previously thought untreatable by conventional means.
The Tech That’s Changing Treatment Paradigms
JOGO’s core innovation lies in its patented technology built on the foundational science called EMG-biofeedback, which fosters new neural pathways to alleviate symptoms and enhance muscle functionality. This technology, backed by clinical studies and FDA approvals, not only promises relief but a return to functionality, charting a new course in medical treatment paradigms.
Navigating through stringent FDA approval processes, JOGO achieved the Breakthrough Device designation, underscoring its potential to significantly improve treatment for debilitating conditions. This designation is supported by robust clinical evidence, including studies from Harvard Medical School that demonstrate JOGO’s superior efficacy over traditional opioids.
Tapping Into a Multi-Billion Dollar Market
The market for treating chronic pain and neuromuscular disorders is vast, projected to exceed $600 billion by 2030. JOGO’s innovative approach positions it to capture a significant portion of this market by offering a safer and more effective alternative to conventional treatments.
JOGO’s Strategic Business Innovation
JOGO Health’s business model is uniquely structured to maximize accessibility and efficacy. By directly selling to patients through referrals from renowned hospitals like Mayo Clinic and Mount Sinai, and offering treatments covered by insurance, JOGO ensures that its revolutionary therapy is within reach for those who need it most. Additionally, JOGO leases its technology to healthcare systems under a monthly arrangement, integrating seamlessly into existing patient care frameworks and enhancing the capability of clinics and hospitals.
This strategic model has fueled rapid growth, with JOGO set to serve 100,000 patients globally and projecting annual revenues exceeding $100 million by 2028. JOGO’s impact is underscored by its FDA Breakthrough Device designation for chronic lower back pain and its extensive use across over 50 hospital partners, treating more than 25,000 patients in over 100,000 sessions. JOGO’s success is further validated by FDA studies and its recognition as a transformative solution in healthcare, reflecting its commitment to advancing treatment while reducing reliance on invasive procedures and medications.
Real Impact on Real Lives
The impact of JOGO’s interventions is best captured through the heartfelt testimonials of those who have regained mobility and quality of life. These personal stories not only highlight the effectiveness of JOGO’s technology but also bring a human touch to its innovations, demonstrating the real-world benefits for patients who had few viable options before.
Conquering Challenges in the Medtech Frontier
In the world of medical technology, navigating the financial and regulatory landscapes is paramount. JOGO Health has effectively tackled these challenges by securing both institutional and crowdfunding sources to finance rigorous clinical trials and FDA approvals. This dual approach not only fuels innovation but also ensures compliance and safety, crucial for treatments affecting human lives.
Simultaneously, JOGO’s customer-centric strategy focuses on addressing deeply felt needs within the healthcare sector. By targeting conditions like stroke, migraines, and chronic pain — areas where current treatments often fall short — JOGO ensures strong customer retention and market penetration. These efforts are supported by maintaining a laser focus on cash flow and continuous product refinement from MVP to full-scale operations, key strategies shared with fellow founders to avoid common pitfalls in the startup journey.
JOGO’s Fundraising Journey and Visionary Impact
Navigating the startup funding landscape, JOGO Health secured crucial investments to propel its mission. Finding a lead investor for follow-on rounds was essential, offering stability and growth. Crowdfunding also strengthened their financial base and expanded their market presence by engaging a broader community.
JOGO’s investment journey is deeply linked to its mission to revolutionize healthcare. Daily, stories of recovery and hope — patients overcoming strokes, living migraine-free, and moving beyond incontinence — fuel their commitment. These narratives affirm JOGO’s transformative impact.
With a $100M pipeline to deploy JOGO’s technology in hospitals and clinics, funding is focused on expanding manufacturing and enhancing the team. This ensures they meet growing demand and continue changing lives daily. For JOGO, this isn’t just a business; it’s a calling, reminding them every morning of the difference they make.
Strategic Moves Toward Global Coverage
As JOGO Health accelerates its journey, the strategy is clear and ambitious. Poised to reach over 100,000 patients worldwide, the company envisions surpassing $100M in annual revenues by 2028, reflecting not just growth but a transformation in healthcare delivery. This expansion is underpinned by innovative direct sales to employers, enhancing their benefits programs with JOGO’s groundbreaking solutions. A notable partnership with a leading pharmaceutical company marks the beginning of what promises to be a series of strategic alliances with major industry players, including tech giants from Silicon Valley.
JOGO is also expanding its B2B leasing model, aiming to place devices in over 70,000 regional physician offices specializing in neurology, pain management, and gastroenterology. This expansion isn’t limited to domestic borders — JOGO aims to become the primary treatment for chronic pain and neuromuscular disorders globally.
With a solid product-market fit and robust insurance reimbursements, JOGO is raising capital to scale its impact. The goal is to integrate JOGO devices into over a million physicians’ offices, rehabilitation centers, and homes worldwide. This bold vision drives JOGO toward a future where its solutions are essential in global healthcare.
Supporting a Healthier Tomorrow
As JOGO Health continues to break barriers and set new standards, the invitation is extended to investors and partners to join this transformative journey. By investing in JOGO, you’ll align with venture investors like Hourglass Ventures and Mayo Clinic, the world’s leading hospital. Together, you can help champion a future where over 1.5 billion people are free from chronic pain and neuromuscular limitations, paving the way for a healthier tomorrow.
